 Justin Honce
Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 16 | 2024 | 3566 | 1.050 |
Why?
| | Comprehension | 1 | 2025 | 172 | 0.830 |
Why?
| | Multiple Sclerosis | 4 | 2021 | 455 | 0.750 |
Why?
| | Immunologic Factors | 2 | 2019 | 236 | 0.640 |
Why?
| | Glatiramer Acetate | 1 | 2019 | 18 | 0.610 |
Why?
| | Psychotherapy | 1 | 2020 | 167 | 0.590 |
Why?
| | Rituximab | 1 | 2019 | 176 | 0.560 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2019 | 76 | 0.560 |
Why?
| | Epilepsy | 2 | 2017 | 333 | 0.470 |
Why?
| | Neuroimaging | 1 | 2016 | 259 | 0.430 |
Why?
| | Meningeal Neoplasms | 3 | 2021 | 100 | 0.350 |
Why?
| | Cochlear Implantation | 2 | 2023 | 76 | 0.320 |
Why?
| | Cochlear Implants | 2 | 2023 | 91 | 0.320 |
Why?
| | Natalizumab | 2 | 2021 | 40 | 0.320 |
Why?
| | Meningioma | 2 | 2021 | 91 | 0.310 |
Why?
| | Brain Concussion | 1 | 2016 | 574 | 0.290 |
Why?
| | Central Nervous System | 2 | 2021 | 258 | 0.280 |
Why?
| | Brain | 5 | 2024 | 2668 | 0.280 |
Why?
| | Pyrazoles | 3 | 2021 | 423 | 0.260 |
Why?
| | Pyrimidines | 2 | 2021 | 470 | 0.260 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 1081 | 0.240 |
Why?
| | Middle Aged | 16 | 2025 | 33479 | 0.230 |
Why?
| | Pyridines | 2 | 2021 | 506 | 0.230 |
Why?
| | Atrophy | 2 | 2024 | 184 | 0.230 |
Why?
| | Frontotemporal Dementia | 1 | 2024 | 57 | 0.220 |
Why?
| | Central Nervous System Diseases | 1 | 2023 | 69 | 0.190 |
Why?
| | Humans | 27 | 2025 | 137585 | 0.180 |
Why?
| | Intracranial Aneurysm | 1 | 2022 | 97 | 0.180 |
Why?
| | Adult | 12 | 2025 | 37929 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-ret | 1 | 2021 | 36 | 0.180 |
Why?
| | Patient Satisfaction | 1 | 2025 | 660 | 0.180 |
Why?
| | Lung Neoplasms | 3 | 2021 | 2526 | 0.180 |
Why?
| | Relaxation Therapy | 1 | 2020 | 17 | 0.170 |
Why?
| | Hypnosis | 1 | 2020 | 11 | 0.170 |
Why?
| | Parkinson Disease | 2 | 2017 | 493 | 0.170 |
Why?
| | Radiology, Interventional | 1 | 2020 | 33 | 0.160 |
Why?
| | Radiology Department, Hospital | 1 | 2019 | 16 | 0.160 |
Why?
| | Software | 1 | 2024 | 665 | 0.160 |
Why?
| | Skull Base Neoplasms | 1 | 2019 | 30 | 0.150 |
Why?
| | Maintenance Chemotherapy | 1 | 2019 | 35 | 0.150 |
Why?
| | Cerebral Arterial Diseases | 1 | 2019 | 47 | 0.150 |
Why?
| | Neurologic Examination | 1 | 2019 | 110 | 0.150 |
Why?
| | Induction Chemotherapy | 1 | 2019 | 76 | 0.150 |
Why?
| | Antineoplastic Agents | 2 | 2021 | 2129 | 0.150 |
Why?
| | Lactams, Macrocyclic | 1 | 2018 | 49 | 0.150 |
Why?
| | Alzheimer Disease | 1 | 2024 | 560 | 0.150 |
Why?
| | Blepharospasm | 1 | 2018 | 7 | 0.150 |
Why?
| | Torticollis | 1 | 2018 | 12 | 0.150 |
Why?
| | Demyelinating Diseases | 1 | 2019 | 85 | 0.140 |
Why?
| | Basal Ganglia | 1 | 2018 | 56 | 0.140 |
Why?
| | Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 11 | 0.140 |
Why?
| | Organophosphorus Compounds | 1 | 2018 | 78 | 0.140 |
Why?
| | Fingolimod Hydrochloride | 1 | 2018 | 40 | 0.140 |
Why?
| | Sinus Thrombosis, Intracranial | 1 | 2017 | 21 | 0.130 |
Why?
| | Disability Evaluation | 1 | 2019 | 290 | 0.130 |
Why?
| | Male | 15 | 2025 | 67762 | 0.130 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2017 | 38 | 0.130 |
Why?
| | Brain Neoplasms | 2 | 2016 | 1238 | 0.130 |
Why?
| | Academic Medical Centers | 1 | 2019 | 512 | 0.130 |
Why?
| | Spin Labels | 1 | 2016 | 48 | 0.130 |
Why?
| | Female | 15 | 2025 | 73304 | 0.130 |
Why?
| | Cerebellum | 1 | 2018 | 224 | 0.130 |
Why?
| | Surgery, Computer-Assisted | 1 | 2017 | 101 | 0.120 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 80 | 0.120 |
Why?
| | Medical Marijuana | 1 | 2017 | 117 | 0.120 |
Why?
| | Laser Therapy | 1 | 2017 | 130 | 0.120 |
Why?
| | Brain Ischemia | 1 | 2019 | 338 | 0.120 |
Why?
| | Gray Matter | 1 | 2015 | 80 | 0.110 |
Why?
| | Surveys and Questionnaires | 2 | 2025 | 5778 | 0.110 |
Why?
| | Gene Rearrangement | 1 | 2015 | 150 | 0.110 |
Why?
| | Cerebrovascular Circulation | 1 | 2016 | 243 | 0.110 |
Why?
| | Mitochondrial Diseases | 1 | 2015 | 91 | 0.110 |
Why?
| | Neurosurgical Procedures | 1 | 2016 | 197 | 0.110 |
Why?
| | Double-Blind Method | 1 | 2019 | 1993 | 0.110 |
Why?
| | Immunosuppressive Agents | 1 | 2019 | 890 | 0.110 |
Why?
| | Nucleus Accumbens | 1 | 2015 | 138 | 0.100 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2015 | 234 | 0.100 |
Why?
| | Endovascular Procedures | 1 | 2017 | 312 | 0.100 |
Why?
| | Anxiety | 1 | 2020 | 1035 | 0.100 |
Why?
| | Glioma | 1 | 2016 | 395 | 0.090 |
Why?
| | Health Services Accessibility | 1 | 2019 | 986 | 0.090 |
Why?
| | Contrast Media | 3 | 2021 | 467 | 0.090 |
Why?
| | Quality Improvement | 1 | 2019 | 1178 | 0.090 |
Why?
| | Brain Injuries | 1 | 2016 | 494 | 0.090 |
Why?
| | Artifacts | 2 | 2023 | 129 | 0.090 |
Why?
| | Diagnosis, Differential | 1 | 2015 | 1483 | 0.080 |
Why?
| | Stroke | 1 | 2019 | 1120 | 0.080 |
Why?
| | Cannabis | 1 | 2017 | 494 | 0.080 |
Why?
| | Hippocampus | 1 | 2015 | 895 | 0.080 |
Why?
| | Young Adult | 3 | 2021 | 13209 | 0.080 |
Why?
| | Aged | 8 | 2024 | 23961 | 0.080 |
Why?
| | Quality of Life | 1 | 2021 | 2892 | 0.080 |
Why?
| | Retrospective Studies | 6 | 2022 | 15657 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2022 | 1946 | 0.070 |
Why?
| | Substance-Related Disorders | 1 | 2015 | 1083 | 0.060 |
Why?
| | Adolescent | 2 | 2021 | 21513 | 0.060 |
Why?
| | Aged, 80 and over | 3 | 2024 | 7635 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2024 | 3284 | 0.050 |
Why?
| | Monkeypox virus | 1 | 2023 | 17 | 0.050 |
Why?
| | Angiography, Digital Subtraction | 1 | 2022 | 44 | 0.050 |
Why?
| | Cerebral Angiography | 1 | 2022 | 109 | 0.050 |
Why?
| | Computed Tomography Angiography | 1 | 2022 | 129 | 0.040 |
Why?
| | Dementia | 1 | 2024 | 259 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 611 | 0.040 |
Why?
| | Disease Progression | 2 | 2019 | 2757 | 0.040 |
Why?
| | Hospital Bed Capacity, 500 and over | 1 | 2019 | 6 | 0.040 |
Why?
| | Time Management | 1 | 2019 | 20 | 0.040 |
Why?
| | Magnets | 1 | 2019 | 19 | 0.040 |
Why?
| | Transportation of Patients | 1 | 2019 | 55 | 0.040 |
Why?
| | Appointments and Schedules | 1 | 2019 | 89 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2018 | 10811 | 0.040 |
Why?
| | Lactams | 1 | 2018 | 20 | 0.040 |
Why?
| | Artificial Intelligence | 1 | 2022 | 279 | 0.040 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 140 | 0.040 |
Why?
| | Prognosis | 2 | 2019 | 4030 | 0.040 |
Why?
| | Drug Approval | 1 | 2018 | 88 | 0.040 |
Why?
| | Tomography Scanners, X-Ray Computed | 1 | 2018 | 20 | 0.040 |
Why?
| | Aminopyridines | 1 | 2018 | 98 | 0.040 |
Why?
| | Databases, Bibliographic | 1 | 2018 | 32 | 0.040 |
Why?
| | Diffusion Tensor Imaging | 1 | 2018 | 79 | 0.040 |
Why?
| | Gadolinium | 1 | 2018 | 82 | 0.040 |
Why?
| | Dura Mater | 1 | 2017 | 34 | 0.030 |
Why?
| | Lymphoma, B-Cell | 1 | 2018 | 106 | 0.030 |
Why?
| | Memory Disorders | 1 | 2017 | 164 | 0.030 |
Why?
| | Mood Disorders | 1 | 2017 | 133 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 658 | 0.030 |
Why?
| | Radiosurgery | 1 | 2019 | 344 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2018 | 786 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 322 | 0.030 |
Why?
| | Memory | 1 | 2017 | 248 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1060 | 0.030 |
Why?
| | Inpatients | 1 | 2019 | 500 | 0.030 |
Why?
| | Fatigue | 1 | 2017 | 329 | 0.030 |
Why?
| | Limbic System | 1 | 2015 | 47 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1325 | 0.030 |
Why?
| | Affect | 1 | 2017 | 292 | 0.030 |
Why?
| | Tremor | 1 | 2015 | 65 | 0.030 |
Why?
| | Gait Disorders, Neurologic | 1 | 2015 | 46 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1236 | 0.030 |
Why?
| | Length of Stay | 1 | 2019 | 1215 | 0.030 |
Why?
| | Marijuana Smoking | 1 | 2017 | 252 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2031 | 0.030 |
Why?
| | Internet | 1 | 2017 | 655 | 0.020 |
Why?
| | Anticoagulants | 1 | 2017 | 664 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2022 | 2691 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2828 | 0.020 |
Why?
| | Colorado | 1 | 2019 | 4565 | 0.020 |
Why?
| | Sex Factors | 1 | 2015 | 2071 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5131 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 6828 | 0.020 |
Why?
| | Obesity | 1 | 2017 | 2992 | 0.010 |
Why?
|
|
Honce's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|